Benzene

Benzene

SCHEMBL4457063

CC(=O)OCC(=O)O.c1ccccc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
LMNA P02545 2/20 0.46
HSD17B10 Q99714 1/20 0.46
PAM P19021 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.41
ALOX15 P16050 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
TSHR P16473 1/20 0.39
CTH P32929 1/20 0.39
CBS P35520 1/20 0.39
THPO P40225 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL226224 0.94
SCHEMBL3094437 0.92 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10PAMSMN1; SMN2
SCHEMBL29895487 0.92
SCHEMBL27811242 0.92
Hydrochloric Acid SCHEMBL1059764 0.92
SCHEMBL2301240 0.92
SCHEMBL15820834 0.92
Water SCHEMBL9869136 0.92
Ammonia Solution, Strong SCHEMBL22832177 0.92
Bromide SCHEMBL27837656 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207972-A1 Propylene polymer catalyst donor component INEOS USA LLC 2008-08-28 US claimed
EP-1863855-A2 PROPYLENE POLYMER CATALYST DONOR COMPONENT INEOS USA LLC (US) 2007-12-12 EP claimed
US-20070179047-A1 Propylene polymer catalyst donor component INNOVENE USA (US) 2007-08-02 US claimed
WO-2006096621-A2 PROPYLENE POLYMER CATALYST DONOR COMPONENT INNOVENE USA LLC (US) 2006-09-14 WO claimed
US-7491781-B2 Propylene polymer catalyst donor component INEOS USA LLC (US) 2009-02-17 US disclosed
US-20080207972-A1 Propylene polymer catalyst donor component INEOS USA LLC 2008-08-28 US disclosed
EP-1863855-A2 PROPYLENE POLYMER CATALYST DONOR COMPONENT INEOS USA LLC (US) 2007-12-12 EP disclosed
US-20070179047-A1 Propylene polymer catalyst donor component INNOVENE USA (US) 2007-08-02 US disclosed
WO-2006096621-A2 PROPYLENE POLYMER CATALYST DONOR COMPONENT INNOVENE USA LLC (US) 2006-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207972-A1 Propylene polymer catalyst donor component RAD52, NR2C2, PGR ALDH1A1 4642/4885LMNA 4627/4885HSD17B10 1688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.